Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
EBITDA Growth
-12.92%
TTM · Period ending:
TEVA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-12.92%period ending
Latest reported-12.92%period ending
TEVA TTM EBITDA YoY % (446.25% → -12.92%)
Year-over-year change
High-resolution chart · PNG
TEVA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 52.2395% | |
| 91.2158% | |
| 92.2801% | |
| 48.1683% | |
| 66.9743% | |
| 54.1688% | |
| 49.2516% | |
| 134.1267% | |
| 152.7554% | |
| 337.0248% | |
| -20.4258% | |
| -300.8627% | |
| -236.0368% | |
| -129.1426% | |
| 34.4161% | |
| -12.1011% | |
| -6.9739% | |
| 36.7589% | |
| 12.2396% | |
| 104.987% | |
| 84.917% | |
| 23.7164% | |
| 7.9663% | |
| 6.9252% | |
| 3.5129% | |
| 15.5367% | |
| 21.3879% | |
| -4.8748% | |
| 8.9286% | |
| 24.0654% | |
| 46.2562% | |
| 75.2887% | |
| 62.6556% | |
| 49.9124% | |
| 16.699% | |
| -8.8421% | |
| -8.365% | |
| -19.2362% | |
| 4.888% | |
| 105.1836% | |
| 66.1053% | |
| 51.3919% | |
| -0.2033% | |
| -41.0941% | |
| -22.6384% | |
| 9.3677% | |
| 100.8163% | |
| -55.137% | |
| -60.3871% | |
| -69.4564% | |
| 40.4972% | |
| 18.2304% | |
| 245.4294% | |
| 446.25% |